EUVIMEDEUVIMED entdecken
StudienprotokollOpen Access · CC BY 4.0

Researching COVID to Enhance Recovery (RECOVER) adult study protocol: Rationale, objectives, and design

Leora I Horwitz iD, Tanayott Thaweethai, Shari B Brosnahan, Mine S Cicek, Megan L Fitzgerald, Jason D Goldman, Rachel Hess iD, S L Hodder, Vanessa L Jacoby, Michael R Jordan, Jerry A Krishnan iD, Adeyinka O Laiyemo und 48 weitere

PLOS ONE · 23.06.2023 · 18 (6) · e0286297

DOI: 10.1371/journal.pone.0286297 ↗

Kurz gefasst

Studienprotokoll in der Zeitschrift PLOS ONE, online erschienen am 23.06.2023. Verfasst von Leora I Horwitz und 59 weiteren Autor:innen. Beteiligte Einrichtung: Department of Population Health, NYU Grossman School of Medicine, New York, New York, United States of America. Hauptthemen laut MEDLINE: COVID-19. Die Arbeit wurde bisher 69-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, NICHD NIH HHS, NIAID NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance SARS-CoV-2 infection can result in ongoing, relapsing, or new symptoms or other health effects after the acute phase of infection; termed post-acute sequelae of SARS-CoV-2 infection (PASC), or long COVID. The characteristics, prevalence, trajectory and mechanisms of PASC are ill-defined. The objectives of the Researching COVID to Enhance Recovery (RECOVER) Multi-site Observational Study of PASC in Adults (RECOVER-Adult) are to: (1) characterize PASC prevalence; (2) characterize the symptoms, organ dysfunction, natural history, and distinct phenotypes of PASC; (3) identify demographic, social and clinical risk factors for PASC onset and recovery; and (4) define the biological mechanisms underlying PASC pathogenesis.

Methods

RECOVER-Adult is a combined prospective/retrospective cohort currently planned to enroll 14,880 adults aged ≥18 years. Eligible participants either must meet WHO criteria for suspected, probable, or confirmed infection; or must have evidence of no prior infection. Recruitment occurs at 86 sites in 33 U.S. states, Washington, DC and Puerto Rico, via facility- and community-based outreach. Participants complete quarterly questionnaires about symptoms, social determinants, vaccination status, and interim SARS-CoV-2 infections. In addition, participants contribute biospecimens and undergo physical and laboratory examinations at approximately 0, 90 and 180 days from infection or negative test date, and yearly thereafter. Some participants undergo additional testing based on specific criteria or random sampling. Patient representatives provide input on all study processes. The primary study outcome is onset of PASC, measured by signs and symptoms. A paradigm for identifying PASC cases will be defined and updated using supervised and unsupervised learning approaches with cross-validation. Logistic regression and proportional hazards regression will be conducted to investigate associations between risk factors, onset, and resolution of PASC symptoms.

Discussion

RECOVER-Adult is the first national, prospective, longitudinal cohort of PASC among US adults. Results of this study are intended to inform public health, spur clinical trials, and expand treatment options. Registration NCT05172024 .

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19HumansObservational Studies as TopicPost-Acute COVID-19 SyndromeProspective StudiesRetrospective StudiesSARS-CoV-2AdolescentAdultMulticenter Studies as Topic

Autor:innen und Institutionen

  • Department of Population Health, NYU Grossman School of Medicine, New York, New York, United States of America.
  • Department of Biostatistics, Massachusetts General Hospital, Boston, Massachusetts, United States of America.
  • Division of Pulmonary Critical Care and Sleep Medicine, NYU Langone Health, New York, New York, United States of America.
  • Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, United States of America.
  • Patient Led Research Collaboration on COVID-19, Washington, DC, United States of America.
  • Division of Infectious Diseases, Providence Swedish Medical Center, Seattle, Washington, United States of America.

ORCID-Profile: Leora I Horwitz, Rachel Hess, Jerry A Krishnan, Lauren Nichols, Lauren E Stiles, Heather A Algren, Christian Bime, Mario Castro, Lori B Chibnik, Dominic C Chow, John D Dickinson, Sarah E Donohue, Ivette F Emery, Julio C Facelli

Förderung

  • NIA NIH HHS
  • NICHD NIH HHS
  • NIAID NIH HHS
  • NIGMS NIH HHS
  • NHLBI NIH HHS
  • NIH HHS
  • NCATS NIH HHS
  • NIMHD NIH HHS

Zitieren

APA

Horwitz, L. I., Thaweethai, T., Brosnahan, S. B., Cicek, M. S., Fitzgerald, M. L., Goldman, J. D., Hess, R., Hodder, S. L., Jacoby, V. L., Jordan, M. R., Krishnan, J. A., Laiyemo, A. O., Metz, T. D., Nichols, L., Patzer, R. E., Sekar, A., Singer, N. G., Stiles, L. E., Taylor, B. S., …, & Gallagher, E. J. (2023). Researching COVID to Enhance Recovery (RECOVER) adult study protocol: Rationale, objectives, and design. PLOS ONE, 18(6), e0286297. https://doi.org/10.1371/journal.pone.0286297

Vancouver

Horwitz LI, Thaweethai T, Brosnahan SB, Cicek MS, Fitzgerald ML, Goldman JD, et al. Researching COVID to Enhance Recovery (RECOVER) adult study protocol: Rationale, objectives, and design. PLOS ONE. 2023;18(6):e0286297. doi:10.1371/journal.pone.0286297

BibTeX
@article{Horwitz2023,
  author = {Horwitz, Leora I and Thaweethai, Tanayott and Brosnahan, Shari B and Cicek, Mine S and Fitzgerald, Megan L and Goldman, Jason D and Hess, Rachel and Hodder, S L and Jacoby, Vanessa L and Jordan, Michael R and Krishnan, Jerry A and Laiyemo, Adeyinka O and Metz, Torri D and Nichols, Lauren and Patzer, Rachel E and Sekar, Anisha and Singer, Nora G and Stiles, Lauren E and Taylor, Barbara S and Ahmed, Shifa and Algren, Heather A and Anglin, Khamal and Aponte-Soto, Lisa and Ashktorab, Hassan and Bassett, Ingrid V and Bedi, Brahmchetna and Bhadelia, Nahid and Bime, Christian and Bind, Marie-Abele C and Black, Lora J and Blomkalns, Andra L and Brim, Hassan and Castro, Mario and Chan, James and Charney, Alexander W and Chen, Benjamin K and Chen, Li Qing and Chen, Peter and Chestek, David and Chibnik, Lori B and Chow, Dominic C and Chu, Helen Y and Clifton, Rebecca G and Collins, Shelby and Costantine, Maged M and Cribbs, Sushma K and Deeks, Steven G and Dickinson, John D and Donohue, Sarah E and Durstenfeld, Matthew S and Emery, Ivette F and Erlandson, Kristine M and Facelli, Julio C and Farah-Abraham, Rachael and Finn, Aloke V and Fischer, Melinda S and Flaherman, Valerie J and Fleurimont, Judes and Fonseca, Vivian and Gallagher, Emily J},
  title = {Researching COVID to Enhance Recovery (RECOVER) adult study protocol: Rationale, objectives, and design},
  journal = {PLOS ONE},
  year = {2023},
  volume = {18},
  number = {6},
  pages = {e0286297},
  doi = {10.1371/journal.pone.0286297}
}
Kostenlos starten →